CONVERTINO, IRMA Statistiche
CONVERTINO, IRMA
DIPARTIMENTO DI MEDICINA CLINICA E SPERIMENTALE
Adherence to mesalazine and identification of patients with ulcerative colitis in healthcare administrative databases of Tuscany (Italy)
2021-01-01 Bartolini, C; Ferraro, S; Convertino, I; Bertani, L; Giometto, S; Costa, F; Blandizzi, C; Lucenteforte, E; Gini, R; Tuccori, M
An overview of the preclinical discovery and development of bamlanivimab for the treatment of novel coronavirus infection (COVID-19): reasons for limited clinical use and lessons for the future
2021-01-01 Tuccori, M.; Convertino, I.; Ferraro, S.; Valdiserra, G.; Cappello, E.; Fini, E.; Focosi, D.
Analysis of fatal adverse drug events recorded in several Italian emergency departments (the MEREAFaPS study)
2021-01-01 Pagani, S.; Lombardi, N.; Crescioli, G.; Vighi, G. V.; Spada, G.; Romoli, I.; Andreetta, P.; Capuano, A.; Marrazzo, E.; Marra, A.; Leoni, O.; Vannacci, A.; Venegoni, M.; Vighi, G. D.; Bettoni, D.; Blandizzi, C.; Bonaiuti, R.; Borsi, V.; Cecchi, E.; Convertino, I.; Del Lungo, M.; Di Mauro, C.; Farina, G.; Ferraro, S.; Fucile, A.; Galfrascoli, E.; Geninatti, E.; Giovannetti, L.; Leonardi, L.; Liccardo, R.; Monina, G.; Mugelli, A.; Pagani, S.; Parrilli, M.; Rafaniello, C.; Rossi, F.; Rostan, S.; Ruocco, M.; Sironi, M.; Sportiello, L.; Tuccori, M.
Diagnostic delay, effectiveness and safety outcomes in a real-world cohort of patients with Crohn's disease: Data from administrative databases in Tuscany, Italy
2021-01-01 Ferraro, S; Bartolini, C; Convertino, I; Bertani, L; Giometto, S; Cappello, E; Valdiserra, G; Tillati, S; Blandizzi, C; Lucenteforte, E; Costa, F; Gini, R; Tuccori, M
Direct health care costs among patients with rheumatoid arthritis before and after the initiation of treatment with JAKi in Tuscany: The LEONARDO study
2021-01-01 Lorenzoni, V; Tuccori, M; Gini, R; Fini, E; Giometto, S; Bartolini, C; Paoletti, O; Convertino, I; Ferraro, S; Cappello, E; Valdiserra, G; Blandizzi, C; Lucenteforte, E; Turchetti, G
Large-Scale Postmarketing Surveillance of Biological Drugs for Immune-Mediated Inflammatory Diseases Through an Italian Distributed Multi-Database Healthcare Network: The VALORE Project
2021-01-01 Trifiro, G.; Isgro, V.; Ingrasciotta, Y.; Ientile, V.; L'Abbate, L.; Foti, S. S.; Belleudi, V.; Poggi, F.; Fontana, A.; Moretti, U.; Lora, R.; Sabaini, A.; Senesi, I.; Sorrentino, C.; Puzo, M. R.; Padula, A.; Fusco, M.; Giordana, R.; Solfrini, V.; Puccini, A.; Rossi, P.; Del Zotto, S.; Leoni, O.; Zanforlini, M.; Ancona, D.; Bavaro, V.; Garau, D.; Ledda, S.; Scondotto, S.; Allotta, A.; Tuccori, M.; Gini, R.; Bucaneve, G.; Franchini, D.; Cavazzana, A.; Biasi, V.; Spila Alegiani, S.; Massari, M.; Trifiro, G.; Foti, S. S.; Andretta, I.; Tanaglia, M.; Puzo, M. R.; Carriero, A.; Sassano, S.; De Sarro, G.; Mirarchi, S.; Palleria, C.; Sarro, C.; Balestrieri, M.; Rostan, S.; Capuano, A.; Bernardi, F. F.; Trama, U.; Russo, A.; Fumo, M. G.; Addis, A.; Musicco, F.; Sapigni, E.; Mazzetti, I.; Podetti, D.; Potenza, A. M.; Nikitina, V.; Ricciardelli, R.; Mogheiseh, N.; Croce, S.; Pettinelli, A.; Ejlli, L.; Fortino, I.; Ercolanoni, M.; Mazzone, A.; Nisic, A.; Schiatti, S.; Ludergnani, M.; Mancini, M.; Patregnani, L.; Fabbietti, P.; Antonicelli, E.; Mangano, A.; Campomori, A.; Urru, S. A.; Costa, G.; Guarrera, G. M.; Stella, P.; Serra, E.; Carta, P.; Vannacci, A.; Lucenteforte, E.; Parrilli, M.; Convertino, I.; De Giorgi, M.; Rocchi, R. E.; Rossi, M.; Scroccaro, G.; Deambrosis, P.; Grindelli, G.; Ferroni, E.
Longitudinal adherence trajectories to biologic disease modifying anti-rheumatic drugs in Tuscany, Italy
2021-01-01 Giometto, S; Convertino, I; Tuccori, M; Gini, R; Cazzato, M; Valdiserra, G; Cappello, E; Ferraro, S; Tillati, S; Fornili, M; Bartolini, C; Paoletti, O; Turchetti, G; Trieste, L; Lorenzoni, V; Blandizzi, C; Mosca, M; Lucenteforte, E
Olfactory and gustatory impairments in COVID-19 patients: Role in early diagnosis and interferences by concomitant drugs
2021-01-01 Ferraro, S.; Tuccori, M.; Convertino, I.; Valdiserra, G.; Cappello, E.; Maggi, F.; Blandizzi, C.; Focosi, D.
Trajectories of adherence to biologic disease-modifying anti-rheumatic drugs in tuscan administrative databases: The pathfinder study
2021-01-01 Convertino, I.; Giometto, S.; Gini, R.; Cazzato, M.; Fornili, M.; Valdiserra, G.; Cappello, E.; Ferraro, S.; Bartolini, C.; Paoletti, O.; Tillati, S.; Baglietto, L.; Turchetti, G.; Trieste, L.; Lorenzoni, V.; Blandizzi, C.; Mosca, M.; Tuccori, M.; Lucenteforte, E.
Trajectories of oral budesonide use in Crohn's disease cohort of Tuscan patients (Italy)
2021-01-01 Bartolini, C; Ferraro, S; Convertino, I; Bertani, L; Giometto, S; Costa, F; Lucenteforte, E; Cappello, E; Valdiserra, G; Blandizzi, C; Gini, R; Tuccori, M
Utilization patterns and healthcare accesses of JAKi used in rheumatoid arthritis patients in Tuscany: The LEONARDO study
2021-01-01 Tuccori, M; Lorenzoni, V; Gini, R; Turchetti, G; Fini, E; Giometto, S; Bartolini, C; Paoletti, O; Convertino, I; Ferraro, S; Cappello, E; Valdiserra, G; Blandizzi, C; Lucenteforte, E
Validation of algorithms for selecting rheumatoid arthritis patients in the Tuscan healthcare administrative databases
2021-01-01 Convertino, I.; Cazzato, M.; Giometto, S.; Gini, R.; Valdiserra, G.; Cappello, E.; Ferraro, S.; Tillati, S.; Bartolini, C.; Paoletti, O.; Lorenzoni, V.; Trieste, L.; Filippi, M.; Turchetti, G.; Cristofano, M.; Blandizzi, C.; Mosca, M.; Lucenteforte, E.; Tuccori, M.
Validation test for algorithms to identify rheumatoid arthritis patients in the Tuscan healthcare administrative databases
2021-01-01 Convertino, I; Cazzato, M; Giometto, S; Gini, R; Lucenteforte, E; Valdiserra, G; Cappello, E; Ferraro, S; Tillati, S; Fornili, M; Bartolini, C; Paoletti, O; Lorenzoni, V; Trieste, L; Filippi, M; Turchetti, G; Cristofano, M; Blandizzi, C; Mosca, M; Tuccori, M
Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline
2020-01-01 Tuccori, M.; Ferraro, S.; Convertino, I.; Cappello, E.; Valdiserra, G.; Blandizzi, C.; Maggi, F.; Focosi, D.
Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patients
2020-01-01 Convertino, I.; Tuccori, M.; Ferraro, S.; Valdiserra, G.; Cappello, E.; Focosi, D.; Blandizzi, C.
Italian Emergency Department Visits and Hospitalizations for Outpatients’ Adverse Drug Events: 12-Year Active Pharmacovigilance Surveillance (The MEREAFaPS Study)
2020-01-01 Lombardi, Niccolò; Crescioli, Giada; Bettiol, Alessandra; Tuccori, Marco; Capuano, Annalisa; Bonaiuti, Roberto; Mugelli, Alessandro; Venegoni, Mauro; Danilo Vighi, Giuseppe; Vannacci, Alfredo; Convertino, Irma
Risk of hospitalisation associated with benzodiazepines and z-drugs in Italy: a nationwide multicentre study in emergency departments
2020-01-01 Lombardi, N.; Bettiol, A.; Crescioli, G.; Ravaldi, C.; Bonaiuti, R.; Venegoni, M.; Vighi, G. D.; Mugelli, A.; Mannaioni, G.; Vannacci, A.; Aiezza, M. L.; Bettoni, D.; Blandizzi, C.; Borsi, V.; Capuano, A.; Cecchi, E.; Convertino, I.; Lungo, M. D.; Mauro, C. D.; Farina, G.; Ferraro, S.; Fucile, A.; Galfrascoli, E.; Geninatti, E.; Giovannetti, L.; Leonardi, L.; Liccardo, R.; Marra, A.; Marrazzo, E.; Monina, G.; Pagani, S.; Parrilli, M.; Rafaniello, C.; Rossi, F.; Rossi, M.; Rostan, S.; Ruocco, M.; Sironi, M.; Spada, G.; Sportiello, L.; Tuccori, M.; Vighi, G. V.
The Impact of the COVID-19 “Infodemic” on Drug-Utilization Behaviors: Implications for Pharmacovigilance
2020-01-01 Tuccori, M.; Convertino, I.; Ferraro, S.; Cappello, E.; Valdiserra, G.; Focosi, D.; Blandizzi, C.
Time to biologic treatment and to total colectomy associated with diagnostic delay in ulcerative colitis: Analysis of an Italian regional administrative healthcare database
2020-01-01 Ferraro, S; Bartolini, C; Bertani, L; Convertino, I; Lucenteforte, E; Costa, F; Valdiserra, G; Cappello, E; Blandizzi, C; Gini, R; Tuccori, M
Trajectories of use of biologic disease modifying antirheumatic drugs in rheumatoid arthritis: A cohort study of Tuscan patients, Italy
2020-01-01 Convertino, I; Giometto, S; Gini, R; Cazzato, M; Valdiserra, G; Cappello, E; Ferraro, S; Fornili, M; Turchetti, G; Lorenzoni, V; Trieste, L; Mosca, M; Blandizzi, C; Tuccori, M; Lucenteforte, E
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Adherence to mesalazine and identification of patients with ulcerative colitis in healthcare administrative databases of Tuscany (Italy) | 1-gen-2021 | Bartolini, C; Ferraro, S; Convertino, I; Bertani, L; Giometto, S; Costa, F; Blandizzi, C; Lucenteforte, E; Gini, R; Tuccori, M | |
| An overview of the preclinical discovery and development of bamlanivimab for the treatment of novel coronavirus infection (COVID-19): reasons for limited clinical use and lessons for the future | 1-gen-2021 | Tuccori, M.; Convertino, I.; Ferraro, S.; Valdiserra, G.; Cappello, E.; Fini, E.; Focosi, D. | |
| Analysis of fatal adverse drug events recorded in several Italian emergency departments (the MEREAFaPS study) | 1-gen-2021 | Pagani, S.; Lombardi, N.; Crescioli, G.; Vighi, G. V.; Spada, G.; Romoli, I.; Andreetta, P.; Capuano, A.; Marrazzo, E.; Marra, A.; Leoni, O.; Vannacci, A.; Venegoni, M.; Vighi, G. D.; Bettoni, D.; Blandizzi, C.; Bonaiuti, R.; Borsi, V.; Cecchi, E.; Convertino, I.; Del Lungo, M.; Di Mauro, C.; Farina, G.; Ferraro, S.; Fucile, A.; Galfrascoli, E.; Geninatti, E.; Giovannetti, L.; Leonardi, L.; Liccardo, R.; Monina, G.; Mugelli, A.; Pagani, S.; Parrilli, M.; Rafaniello, C.; Rossi, F.; Rostan, S.; Ruocco, M.; Sironi, M.; Sportiello, L.; Tuccori, M. | |
| Diagnostic delay, effectiveness and safety outcomes in a real-world cohort of patients with Crohn's disease: Data from administrative databases in Tuscany, Italy | 1-gen-2021 | Ferraro, S; Bartolini, C; Convertino, I; Bertani, L; Giometto, S; Cappello, E; Valdiserra, G; Tillati, S; Blandizzi, C; Lucenteforte, E; Costa, F; Gini, R; Tuccori, M | |
| Direct health care costs among patients with rheumatoid arthritis before and after the initiation of treatment with JAKi in Tuscany: The LEONARDO study | 1-gen-2021 | Lorenzoni, V; Tuccori, M; Gini, R; Fini, E; Giometto, S; Bartolini, C; Paoletti, O; Convertino, I; Ferraro, S; Cappello, E; Valdiserra, G; Blandizzi, C; Lucenteforte, E; Turchetti, G | |
| Large-Scale Postmarketing Surveillance of Biological Drugs for Immune-Mediated Inflammatory Diseases Through an Italian Distributed Multi-Database Healthcare Network: The VALORE Project | 1-gen-2021 | Trifiro, G.; Isgro, V.; Ingrasciotta, Y.; Ientile, V.; L'Abbate, L.; Foti, S. S.; Belleudi, V.; Poggi, F.; Fontana, A.; Moretti, U.; Lora, R.; Sabaini, A.; Senesi, I.; Sorrentino, C.; Puzo, M. R.; Padula, A.; Fusco, M.; Giordana, R.; Solfrini, V.; Puccini, A.; Rossi, P.; Del Zotto, S.; Leoni, O.; Zanforlini, M.; Ancona, D.; Bavaro, V.; Garau, D.; Ledda, S.; Scondotto, S.; Allotta, A.; Tuccori, M.; Gini, R.; Bucaneve, G.; Franchini, D.; Cavazzana, A.; Biasi, V.; Spila Alegiani, S.; Massari, M.; Trifiro, G.; Foti, S. S.; Andretta, I.; Tanaglia, M.; Puzo, M. R.; Carriero, A.; Sassano, S.; De Sarro, G.; Mirarchi, S.; Palleria, C.; Sarro, C.; Balestrieri, M.; Rostan, S.; Capuano, A.; Bernardi, F. F.; Trama, U.; Russo, A.; Fumo, M. G.; Addis, A.; Musicco, F.; Sapigni, E.; Mazzetti, I.; Podetti, D.; Potenza, A. M.; Nikitina, V.; Ricciardelli, R.; Mogheiseh, N.; Croce, S.; Pettinelli, A.; Ejlli, L.; Fortino, I.; Ercolanoni, M.; Mazzone, A.; Nisic, A.; Schiatti, S.; Ludergnani, M.; Mancini, M.; Patregnani, L.; Fabbietti, P.; Antonicelli, E.; Mangano, A.; Campomori, A.; Urru, S. A.; Costa, G.; Guarrera, G. M.; Stella, P.; Serra, E.; Carta, P.; Vannacci, A.; Lucenteforte, E.; Parrilli, M.; Convertino, I.; De Giorgi, M.; Rocchi, R. E.; Rossi, M.; Scroccaro, G.; Deambrosis, P.; Grindelli, G.; Ferroni, E. | |
| Longitudinal adherence trajectories to biologic disease modifying anti-rheumatic drugs in Tuscany, Italy | 1-gen-2021 | Giometto, S; Convertino, I; Tuccori, M; Gini, R; Cazzato, M; Valdiserra, G; Cappello, E; Ferraro, S; Tillati, S; Fornili, M; Bartolini, C; Paoletti, O; Turchetti, G; Trieste, L; Lorenzoni, V; Blandizzi, C; Mosca, M; Lucenteforte, E | |
| Olfactory and gustatory impairments in COVID-19 patients: Role in early diagnosis and interferences by concomitant drugs | 1-gen-2021 | Ferraro, S.; Tuccori, M.; Convertino, I.; Valdiserra, G.; Cappello, E.; Maggi, F.; Blandizzi, C.; Focosi, D. | |
| Trajectories of adherence to biologic disease-modifying anti-rheumatic drugs in tuscan administrative databases: The pathfinder study | 1-gen-2021 | Convertino, I.; Giometto, S.; Gini, R.; Cazzato, M.; Fornili, M.; Valdiserra, G.; Cappello, E.; Ferraro, S.; Bartolini, C.; Paoletti, O.; Tillati, S.; Baglietto, L.; Turchetti, G.; Trieste, L.; Lorenzoni, V.; Blandizzi, C.; Mosca, M.; Tuccori, M.; Lucenteforte, E. | |
| Trajectories of oral budesonide use in Crohn's disease cohort of Tuscan patients (Italy) | 1-gen-2021 | Bartolini, C; Ferraro, S; Convertino, I; Bertani, L; Giometto, S; Costa, F; Lucenteforte, E; Cappello, E; Valdiserra, G; Blandizzi, C; Gini, R; Tuccori, M | |
| Utilization patterns and healthcare accesses of JAKi used in rheumatoid arthritis patients in Tuscany: The LEONARDO study | 1-gen-2021 | Tuccori, M; Lorenzoni, V; Gini, R; Turchetti, G; Fini, E; Giometto, S; Bartolini, C; Paoletti, O; Convertino, I; Ferraro, S; Cappello, E; Valdiserra, G; Blandizzi, C; Lucenteforte, E | |
| Validation of algorithms for selecting rheumatoid arthritis patients in the Tuscan healthcare administrative databases | 1-gen-2021 | Convertino, I.; Cazzato, M.; Giometto, S.; Gini, R.; Valdiserra, G.; Cappello, E.; Ferraro, S.; Tillati, S.; Bartolini, C.; Paoletti, O.; Lorenzoni, V.; Trieste, L.; Filippi, M.; Turchetti, G.; Cristofano, M.; Blandizzi, C.; Mosca, M.; Lucenteforte, E.; Tuccori, M. | |
| Validation test for algorithms to identify rheumatoid arthritis patients in the Tuscan healthcare administrative databases | 1-gen-2021 | Convertino, I; Cazzato, M; Giometto, S; Gini, R; Lucenteforte, E; Valdiserra, G; Cappello, E; Ferraro, S; Tillati, S; Fornili, M; Bartolini, C; Paoletti, O; Lorenzoni, V; Trieste, L; Filippi, M; Turchetti, G; Cristofano, M; Blandizzi, C; Mosca, M; Tuccori, M | |
| Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline | 1-gen-2020 | Tuccori, M.; Ferraro, S.; Convertino, I.; Cappello, E.; Valdiserra, G.; Blandizzi, C.; Maggi, F.; Focosi, D. | |
| Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patients | 1-gen-2020 | Convertino, I.; Tuccori, M.; Ferraro, S.; Valdiserra, G.; Cappello, E.; Focosi, D.; Blandizzi, C. | |
| Italian Emergency Department Visits and Hospitalizations for Outpatients’ Adverse Drug Events: 12-Year Active Pharmacovigilance Surveillance (The MEREAFaPS Study) | 1-gen-2020 | Lombardi, Niccolò; Crescioli, Giada; Bettiol, Alessandra; Tuccori, Marco; Capuano, Annalisa; Bonaiuti, Roberto; Mugelli, Alessandro; Venegoni, Mauro; Danilo Vighi, Giuseppe; Vannacci, Alfredo; Convertino, Irma | |
| Risk of hospitalisation associated with benzodiazepines and z-drugs in Italy: a nationwide multicentre study in emergency departments | 1-gen-2020 | Lombardi, N.; Bettiol, A.; Crescioli, G.; Ravaldi, C.; Bonaiuti, R.; Venegoni, M.; Vighi, G. D.; Mugelli, A.; Mannaioni, G.; Vannacci, A.; Aiezza, M. L.; Bettoni, D.; Blandizzi, C.; Borsi, V.; Capuano, A.; Cecchi, E.; Convertino, I.; Lungo, M. D.; Mauro, C. D.; Farina, G.; Ferraro, S.; Fucile, A.; Galfrascoli, E.; Geninatti, E.; Giovannetti, L.; Leonardi, L.; Liccardo, R.; Marra, A.; Marrazzo, E.; Monina, G.; Pagani, S.; Parrilli, M.; Rafaniello, C.; Rossi, F.; Rossi, M.; Rostan, S.; Ruocco, M.; Sironi, M.; Spada, G.; Sportiello, L.; Tuccori, M.; Vighi, G. V. | |
| The Impact of the COVID-19 “Infodemic” on Drug-Utilization Behaviors: Implications for Pharmacovigilance | 1-gen-2020 | Tuccori, M.; Convertino, I.; Ferraro, S.; Cappello, E.; Valdiserra, G.; Focosi, D.; Blandizzi, C. | |
| Time to biologic treatment and to total colectomy associated with diagnostic delay in ulcerative colitis: Analysis of an Italian regional administrative healthcare database | 1-gen-2020 | Ferraro, S; Bartolini, C; Bertani, L; Convertino, I; Lucenteforte, E; Costa, F; Valdiserra, G; Cappello, E; Blandizzi, C; Gini, R; Tuccori, M | |
| Trajectories of use of biologic disease modifying antirheumatic drugs in rheumatoid arthritis: A cohort study of Tuscan patients, Italy | 1-gen-2020 | Convertino, I; Giometto, S; Gini, R; Cazzato, M; Valdiserra, G; Cappello, E; Ferraro, S; Fornili, M; Turchetti, G; Lorenzoni, V; Trieste, L; Mosca, M; Blandizzi, C; Tuccori, M; Lucenteforte, E |